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Lactase deficiency can lead to significant symptoms in 
the pediatric population. To date, few studies have ex-
amined the prevalence of enzyme testing-based lactase 
and other disaccharidase deficiencies (DDs) in pediat-
ric patients undergoing upper endoscopic evaluation. 
The primary objective of this study was to determine 
the prevalence of selective lactase and other DDs 
amongst a large cohort of pediatric patients with and 
without inflammatory bowel disease (IBD: Crohn’s 
disease and ulcerative colitis) via a chart review of 739 
patients who underwent esophago-gastro-dudenoscopy 
EGD between April 2010 and August 2016. We identi-
fied 560 pediatric patients (ages 1-18 years) who un-
derwent mucosal enzyme testing at the time of their 
EGD. The overall rate of lactase deficiency (LD) was 
39%. LD positively correlated with age (p=0.00017), 
but there was no significant difference between age 
matched IBD and non-IBD patients (45% vs. 42% 
p=0.68). Four patients (0.17%) were found to have 
selective maltase deficiency. No selective sucrase or 
palatinase deficiency was identified. Statistically sig-
nificant differences occurred in lactase deficiency 
amongst patients of different races. In conclusion, lac-
tase deficiency is a relatively common finding in chil-
dren undergoing EGD though at no increased rate 
amongst the IBD patient population. Disaccharidase 
testing should be considered in pediatric patients un-
dergoing EGD. 
Research Article 
Annie Goodwin1, Lina Karam1, G S Gopalakrishna1 and Richard Kellermayer1,2 
1 Section of Pediatric Gastroenterology, Department of Pediatrics, Baylor College of Medicine, Texas Children’s Hospital, 
Houston, TX, USA 
2 USDA/ARS Children’s Nutrition Research Center, Houston, TX, USA 
Received on April 11, 2018; Accepted on May 14, 2018; Published on May 31, 2018 
Correspondence should be addressed to Richard Kellermayer; Tel: +1 713 798 0319; Fax: +1 832 825 3633; Email: 
kellerma@bcm.edu 




Lactose is a disaccharide composed of galactose and 
glucose, most commonly found in mammalian milk 
and milk products. Lactase is the enzyme located on 
the brush border of duodenal and jejunal enterocytes 
that is responsible for the breakdown of this sugar. The 
majority of human infants are born with high levels of 
lactase, as congenital lactase deficiency is an 
extremely rare condition (Diekmann et al. 2015). In 
fact, rather than being born with a paucity of lactase, 
the majority of humans lose lactase activity with 
advancement of age. The symptoms of lactase 
deficiency can include abdominal pain, bloating, 
increased flatulence, and diarrhea, which are caused by 
the processing of undigested lactose by colonic 
bacteria (Heyman 2006). Although lactase deficiency 
is the most common disaccharidase deficiency (DD), 
there are several other disaccharidases, also located on 
the brush border of enterocytes including sucrase, 
maltase, and palatinase. These disaccharidases are 
important in the breakdown of dietary disaccharides.  
     Inflammatory bowel disease (IBD) is a family of 
chronic inflammatory intestinal disorders, including 
Crohn’s disease (CD) and ulcerative colitis (UC) for 
which the etiology is largely unknown. The symptoms 
of IBD flares can be similar to that of lactose 
malabsorption: abdominal pain, diarrhea, bloating. To 
date, there have been few studies examining the 
frequency of lactase deficiency amongst the pediatric 
IBD population; even fewer have looked at that of 
sucrase, maltase, and palatinase (Daileda et al. 2016). 
The purpose of this study was to determine the 
prevalence of selective lactase deficiency amongst a 
large cohort of pediatric patients undergoing 
esophagogastroduodenoscopy (EGD) and compare 
rates amongst IBD and non-IBD patients. A secondary 
aim of this study was to evaluate the rates of sucrase, 
maltase, and palatinase deficiencies in the same cohort.  
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Materials and Methods 
 
Patient Selection 
All cases of upper endoscopic evaluation by two 
physicians at Texas Children’s Hospital between April 
2010 and August 2016 were collected from the 
PedsCORI database (Thakkar et al. 2007). The 
indications for which EGDs were pursued within these 
patients included abdominal pain, nausea/vomiting, 
weight loss, failure to thrive, dysphagia, diarrhea, 
history or concern for celiac disease, history or 
concern for IBD (Table 1). Hospital records for these 
patients were reviewed and mucosal enzyme levels 
were recorded if obtained. Associated demographic 
data including age, sex, and race/ethnicity were also 
extracted and evaluated. The protocol was approved by 
the Baylor College of Medicine Institutional Review 
Board (IRB # H40484)  
 
Mucosal enzyme analysis 
Mucosal biopsies were obtained from the proximal 
duodenum during time of EGD and samples were sent 
to and analyzed at the Children’s Hospital of Buffalo 
certified laboratory. The enzyme activity levels were 
reported in µM/min/g protein with normal reference 
levels of >15 µM/min/g protein for lactase, >25 µM/
min/g protein for surcease, >100 µM/min/g protein for 
maltase and >5.0 µM/min/g protein for palatinase. 
Specific disaccharidase levels were recorded, and 
patients were determined to be disaccharidase deficient 
based on the normal reference range. Given that 
secondary (non-specific) disaccharidase deficiency 
may occur from microvillous damage, patients were 
only categorized as lactase, or selective disaccharidase 
deficient, if all other disaccharidases were normal.  
 
Statistical Analysis 
Unpaired Student T-test was performed for group 
comparisons. Fischer exact test was used to compare 
overall rate of lactase deficiency amongst non-IBD 
patients and IBD patients and to compare rates of 
lactase deficiency between patients of different races. 





A total of 739 charts were examined. Of the 739 
patients, 560 underwent mucosal enzyme testing at the 
time of their EGD. The median age of all patients was 
11 years with a range of 0.17 years to 19 years. The 
most common primary indications for endoscopic 
evaluation included abdominal pain, history of IBD, 
nausea/vomiting, reflux symptoms, and weight loss 
(Table 1). The majority of patients were Caucasian 
(58%). (Table 2). The overall rate of lactase deficiency 
was 39% (220/560). There was a statistically 
significant negative correlation between age and 
lactase level (R= -0.158, p=0.00017) (Figure 1). 
 The youngest patient found to have selective 
lactase deficiency was 1 year of age. No statistically 
significant correlation was seen between levels of 
sucrose, maltase, or palatinase with age. One patient 
underwent endoscopy at multiple time points with 
corresponding mucosal enzyme testing done at the 
same time. The results showed an expected decline of 
lactase levels with increasing age (49.7 µM/min/g at 1 
year of age, 18.5 µM/min/g at 4 years of age, 8 µM/
min/g at 8 years of age). When the study population 
was divided by primary indications for endoscopy, no 
significant difference was seen in lactase levels 
amongst the various groups. 
 There was significant variation in the rate of 
selective lactase deficiency when comparing 
Caucasian patients with patients of other races (Figure 
2). Lactase deficiency was most common among 
African American and Asian patients (65% and 57%, 
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Primary Indication for 
Endoscopy 
Number of Patients (% 
of total) 
Abdominal pain 110 (34.5%) 
IBD 40 (12.5%) 
Nausea/vomiting 38 (11.9%) 
Reflux symptoms 32 (10.0%) 
Other 23 (7.2%) 
Weight loss 22 (6.9%) 
Celiac disease 18 (5.6%) 
Diarrhea 18 (5.6%) 
Failure to thrive 6 (1.9%) 
Eosinophilic esophagitis 3 (0.9%) 
Dysphagia 3 (0.9%) 
Anemia 2 (0.6%) 
Bleeding 2 (0.6%) 
Barrett’s esophagus 1 (0.3%) 
Infection 1 (0.3%) 
Table 1. Primary indications for endoscopic evaluation 
amongst all study subjects greater than 9 years of age. 




African American 46 
American Indian 2 
Unknown 30 
Table 2. Race distribution across patients. 
respectively). These rates were significantly higher 
than the rate of lactase deficiency amongst Caucasian 
patients (28%, p<0.0001). For the cohort of Hispanic 
patients, 51% were found to have selective lactase 
deficiency, again significantly higher than that of 
Caucasian patients (p<0.0001). There was no 
significant difference in rates of selective lactase 
deficiency between the non-caucasian ethnic 
subgroups. The average lactase level of patients within 
each ethnic group under the age of 5 was also 
compared to help elucidate whether patients of certain 
ethnic groups may simply be born with lower levels of 
lactase. Within this age group, there was a significant 
race dependent variation in lactase levels (Figure 3; 
p=0.0078). Under age 5, Hispanic and African 
American children had the lowest average lactase 
levels (14.8 and 13.9, respectively). Additionally, 
within this age group, there was a statistically 
significant difference in average lactase levels when 
comparing the Asian and Hispanic patient population 
(p=0.003); Caucasian to Hispanic population 
(p=0.003); Asian to African American (p=0.0023); and 
the African American to Caucasian populations 
(p=0.03) (Figure 3). 
 The rates of selective deficiencies of the other 
disaccharidases were also examined. Four (0.71%) 
patients had selective maltase deficiency with ages 
ranging from 0.4 years to 9 years. None of these 
patients had a diagnosis of IBD. Three of these 
patients underwent EGD for nausea/vomiting while 
one patient underwent EGD for poor weight gain. No 
selective sucrase or palatinase deficient patients were 
identified. There were a total of 57 patients who were 
found to have pan-DD. Of these patients, 10 had a 
diagnosis of IBD. There was no significant difference 
in the proportion of pan-DD amongst the IBD group as 
compared to the non-IBD group (13.9% vs. 9.6%, 
p=0.29). 
 In order to examine the prevalence of lactase 
deficiency in IBD patients, the overall cohort of our 
study was divided into those with a diagnosis of IBD 
(CD, UC, or IBD unclassified [IBDU]) and those 
without a diagnosis of IBD. The median age of IBD 
patients was higher than the non-IBD patients 
(designated as controls within this sub-analysis). 
Therefore, in order to remove age related lactase level 
bias in the analysis, all patients under the age of 10 
years were excluded from final statistical analysis 
when comparing IBD to the non-IBD groups. The 
resulting two groups after this age correction both had 
a median age of 11 years (p=0.51). The overall rate of 
lactase deficiency in this population of patients was 
43%. The rate of lactase deficiency amongst the IBD 
group was slightly higher (45%) as compared to the 
non-IBD controls (42%), but not significantly (p=0.68) 
(Table 3). Average lactase, sucrase, maltase, and 
palatinase levels were also similar between the two 
groups (Table 4). 
 The rate of lactase deficiency amongst the CD 
specific IBD sub-group was also determined and 
compared to the non-IBD controls. Though the rate of 
lactase deficiency was higher among the CD patients 
compared to non-IBD (50% vs. 42%), this difference 
was not statistically significant (p=0.41). Similarly, 
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Figure 1. Correlation between age and lactase levels. Lactase levels had a significant negative correlation with age (R= -0.158 
p= 0.00017). 
there was no statistically significant difference in the 
rate of lactase deficiency in CD patients when 
compared to patients with UC (50% vs. 37% 




Lactase deficiency can be a significant cause of GI 
discomfort within the pediatric population. 
Furthermore, within the pediatric IBD population, 
lactase deficiency may mimic the symptoms of a 
disease flare. Disaccharidase testing, however, is not a 
routine aspect of IBD monitoring and care. Neither is 
lactose restriction. The purpose of this study was to 
evaluate the rate of selective lactase and other DD 
among IBD patients as compared to that of non-IBD 
patients who underwent EGD evaluation in a large 
pediatric gastroenterology practice. Previous studies 
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Figure 2. Distribution of lactase deficiency by patient race. There was a significant (p=7.56x10-11) race dependent variation in 
lactase activities by ANOVA. Fischer exact testing for Asian to African American (p=0.4144), Asian to Caucasian (p<0.0001), 
Asian to Hispanic (p=0.6086), African American to Caucasians (p<0.0001), Black to Hispanic (p=0.1544) and Caucasians to 
Hispanic (p<0.0001). 
Figure 3. Average lactase levels in patients younger than age 5 amongst various ethnic groups (N= 25 in Hispanic group; N=68 
in Caucasian group; N=14 in Asian group). Again, there was a significant (p=0.0078) race dependent variation in lactase levels 
by ANOVA. Student T testing for Asian to African American (p=0.023), Asian to Caucasians (p=0.291), Asian to Hispanic 
(p=0.003), African American to Caucasians (p=0.030), African American to Hispanic (p=0.405) and Caucasians to Hispanic 
(p=0.003). 
making this comparison within the pediatric 
population have limited their control population to 
those patients with abdominal pain (Pfefferkorn et al. 
2002). This work is unique by its large sample size 
(560 total patients) and by the examination of patients 
with any indication for upper endoscopic evaluation, 
not just abdominal pain. 
 The finding of an overall 39% lactase 
deficiency within our study population is consistent 
with previous studies on lactase deficiency in the 
pediatric population (Daileda et al. 2016). This high 
rate of lactase deficiency supports that testing for DD 
in children with indication for EGD should be 
considered. Given that no significant difference was 
seen in lactase levels by presenting symptomatology, a 
high level of suspicion should hold for all pediatric GI 
patients towards lactase deficiency. The most recent 
cost of the disaccharidase panel was $208 (http://
www.pedsgiwny.com/gi-lab.html). As comparison, the 
same laboratory charged $41 for fecal pancreatic 
elastase testing. Based on this information, we 
recommend careful cost/benefit calculation to consider 
maximizing the value of an already indicated invasive 
procedure (EGD) in the vulnerable pediatric 
population by examining disaccharidase levels with a 
rather high (~39%) diagnostic yield. 
 Although the rate of selective lactase 
deficiency was higher in the IBD population (45%), 
this was not found to be statistically significant when 
corrected for age. This lack of correlation between 
IBD and lactase deficiency is consistent with a study 
by Pfefferkorn et al. (2002). Although CD would be 
expected to have greater small bowel involvement and 
possible secondary lactase deficiency, there was no 
significant difference between CD and UC patients in 
this respect. This supports the idea that lactase 
deficiency in IBD patients is not a result of mucosal 
inflammation, but can be a separate and common 
entity, which should be evaluated for at first 
endoscopic assessment if possible. 
 Although histologic inflammation was not 
specifically examined in this study, previous work has 
been inconclusive in regards to the relationship 
between histologic inflammation and disaccharidase 
activity. Some studies showed lack of correlation 
between disaccharidase activity and histopathologic 
findings, while others found an inverse relationship 
between these measures (Gupta et al. 1999, Harrison 
& Walker-Smith 1977, Shulman et al. 1991, Tori et al. 
2007). To eliminate incidence of secondary pan-
disaccharidase deficiency due to microvilli destruction, 
patients with concurrent maltase, sucrase, or palatinase 
deficiency were excluded when calculating rates of 
lactase deficiency in this study. Of the study 
population, 57 (10.2%) were found to have pan-DD. 
Interestingly, there was no significant difference in 
rates of pan-DD when comparing IBD patients with 
non-IBD patients (p=0.29). This seems to suggest that 
the inflammation associated with IBD may not result 
in higher incidence of pan-disaccharidase deficiency 
secondary to microvillous destruction. 
 Although no significant difference in rates of 
lactase deficiency was seen in IBD versus non-IBD 
patients, the results of this study did show a significant 
difference in rates of lactase deficiency between 
various ethnic groups when compared to Caucasian 
patients. The highest rates were found in African 
American and Asian patients (65% and 57%, 
respectively), while Caucasian patients had the lowest 
rate of lactase deficiency (28%). Similar results were 
seen in a Finnish study comparing children of Finnish 
descent to children of African descent (Kolho & 
Savilahti, 2000). Likewise, in one adult British study, 
the rate of lactase deficiency was found to be higher in 
non-Caucasian patients when compared to Caucasian 
adults (Ferguson et al. 1984). Although adult studies 
have shown these ethnic differences in rates of lactase 
deficiency, the results of our work indicate that similar 
differences exist within the pediatric population and 
adds knowledge about the higher levels of lactase 
deficiency in Hispanic children compared to 
Caucasians. It is of interest to note that previous work 
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Table 3. Rates of lactase deficiency in all patients greater 
than 9 years of age, IBD versus non-IBD.  
  Average Lactase level Average Sucrase level Average Maltase level 
Average Palatinase 
level 
IBD 14.3 52.3 153.0 10.8 
Non-IBD 15.9 54.4 157.2 11.2 
P-value p=0.47 p=0.55 p=0.63 p=0.65 
Table 4. Average disaccharidase levels amongst the IBD versus non-IBD groups.  
by Kirschner et al. (1981) noted an increased rate of 
lactose malabsorption as determined by lactose breath 
hydrogen test within the Caucasian Jewish population 
as compared to Caucasian non-Jewish population. 
Given the retrospective nature of our study, a similar 
comparison was not able to be made using tissue 
mucosal enzyme studies to determine how the 
proportion of Jewish patients may have influenced our 
results. Therefore, this question would be worthwhile 
to examine in the future. 
 It is also unclear whether children of certain 
ethnicities are simply born with lower levels of lactase, 
or whether they lose enzyme activity at a faster rate, or 
a combination of the two. To address this question, we 
compared average lactase levels amongst patients 
under 5 years of age within each ethnic group. There 
was significantly lower average lactase level in young 
Hispanic children compared to Asians or Caucasians. 
This suggests that Hispanic children may be born with 
lower lactase levels as compared to their Asian and 
Caucasian counterparts. In the meantime, Asian 
children may lose lactase activity at a higher rate than 
Caucasians, since they are more commonly lactase 
deficient than Caucasians later in childhood. However, 
the small sample size within each ethnic group below 
age 5 was relatively low for this comparison (Figure 3: 
N=25 in Hispanic group; N=68 in non-Hispanic 
Whites group; N=14 in Asian group). Therefore, these 
questions should be further addressed in larger groups 
of children before a final conclusion can be brought. 
Nevertheless, our results argue for having a higher 
clinical suspicion for lactase deficiency and 
consequent malabsorption symptoms in non-Caucasian 
pediatric patients. 
 A weakness of this retrospective study is the 
lack of data regarding symptomatology of the patients 
at the time of mucosal biopsy. As studies in irritable 
bowel syndrome (IBS) have shown, there is a 
difference between lactose malabsorption and lactose 
intolerance. Patients may lack adequate enzymatic 
activity for the breakdown of lactose, but may not 
show signs or symptoms of lactose intolerance (von 
Tirpitz et al. 2002). Previous studies have also 
revealed increased rates of reported milk intolerance in 
CD as compared to healthy controls, even though there 
was no significant difference in measured duodenal 
lactase enzyme levels (von Tirpitz et al. 2002). A 
study to determine if IBD patients may benefit from a 
lactose free diet secondary to perceived milk 
intolerance despite normal duodenal lactase activity 
would be important to perform in the future. 
 In IBD patients, symptoms of abdominal pain 
and diarrhea often trigger concerns for a potential 
flare. The symptoms of lactase deficiency, however, 
can have many similarities to that of IBD flares. The 
results of this work argue that potential lactase 
deficiency should be considered in these patients. 
Though not significantly different from the non-IBD 
patient population, lactase deficiency occurs at 
relatively high rate within the IBD patients. Studies 
have shown that lactose exposure may have an effect 
on colonic microflora (Szilagyi et al. 2010). This may 
have as of yet unknown consequences on colonic 
inflammation and the course of IBD. The rate of other 
selective DDs (maltase, sucrase, and palatinase) 
appears to occur at a negligible rate amongst the IBD 
population, arguing against routine elimination of 
these disaccharides from the diet. There is no doubt 
that IBD patients often have significant nutritional 
difficulties secondary to chronic inflammation. The 
decision to counsel for a complete avoidance of all 
lactose containing products is a significant one, 
especially given the higher risk of osteopenia amongst 
this group. Screening via mucosal biopsy can therefore 
be an important first step prior to making such 
impactful dietary modifications.  
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